Skip to main
DOCS

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 21 analyst ratings
Hold
Strong Buy 19%
Buy 24%
Hold 48%
Sell 10%
Strong Sell 0%

Bulls say

Doximity is in a good position to benefit from the growing demand for digital health solutions, as evidenced by their strong customer engagement and sales activity. The AI search product is a significant contributor to their forward outlook, which is expected to drive incremental budget opportunities and improve customer interactions through upsell activity. The "No Harm" study has solidified Doximity's market leading reputation among health systems and providers, and their AI search product is fueling a diverse AI pipeline, particularly with the Insights product, which offers significant momentum and value for pharmaceutical companies. Doximity's strong financials and conservative posture towards AI monetization, as well as their successful implementation of the same playbook in monetizing telehealth, makes them a strong contender in the digital health space.

Bears say

Doximity is facing challenges in the competitive market, with slowing growth in both expansion and top customer metrics. The company is also facing a declining number of pharmaceuticals under patent, potentially reducing its revenue opportunity in the marketing solutions segment. Additionally, the company's increased investment in AI compute, engineering, and marketing is leading to compressed margins, and there are limited near-term catalysts for growth. These factors, coupled with a lower growth outlook for FY27, contribute to the negative outlook on Doximity's stock.

Doximity (DOCS) has been analyzed by 21 analysts, with a consensus rating of Hold. 19% of analysts recommend a Strong Buy, 24% recommend Buy, 48% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Hold based on their latest research and market trends.

According to 21 analysts, Doximity (DOCS) has a Hold consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.81, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.81, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.